0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Biochemistry

Buy Now

Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives (Hardcover, 2013 ed.) Loot Price: R1,785
Discovery Miles 17 850
You Save: R1,132 (39%)
Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives (Hardcover, 2013 ed.): Tsukasa Mizuhara

Development of Novel Anti-HIV Pyrimidobenzothiazine Derivatives (Hardcover, 2013 ed.)

Tsukasa Mizuhara

Series: Springer Theses

 (sign in to rate)
List price R2,917 Loot Price R1,785 Discovery Miles 17 850 | Repayment Terms: R167 pm x 12* You Save R1,132 (39%)

Bookmark and Share

Expected to ship within 12 - 17 working days

The author successfully developed novel anti-HIV PD 404182 derivatives that exhibited submicromolar inhibitory activity against both HIV-1 and HIV-2. His thesis is in three parts. The first part expounds efficient methods for the synthesis of tricyclic heterocycles related to PD 404182 based on the sp2-carbon heteroatom bond formations. Starting from arene or haloarene, C O, C N, or C S bonds were formed by simply changing the reactants. These synthetic methods provide powerful approaches for the divergent preparation of pyrimido-benzoxazine, -quinazoline, or -benzothiazine derivatives. The second part explains SAR studies of PD 404182 for the development of anti-HIV agents. Through optimization studies of the central 1,3-thiazin-2-imine core, the benzene and cyclic amidine ring parts, 3-fold more potent inhibitors were obtained compared with the lead compound. The author also reveals by a time-of-drug-addition experiment that PD 404182 derivatives impaired HIV replication at the binding or fusion stage. The third part of the thesis elucidates the development of photoaffinity probes for the target identification of PD 404182. By the photolabeling experiment of HIV-1-infected H9 cells using these probes, the author detected proteins specifically bound to PD 404182. These new anti-HIV agents may be promising agents for anti-HIV therapy because their mechanisms of action differ from those of the currently approved anti-HIV agents.

General

Imprint: Springer Verlag,Japan
Country of origin: Japan
Series: Springer Theses
Release date: October 2013
First published: 2013
Authors: Tsukasa Mizuhara
Dimensions: 235 x 155 x 14mm (L x W x T)
Format: Hardcover
Pages: 151
Edition: 2013 ed.
ISBN-13: 978-4-431-54444-9
Categories: Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
Books > Science & Mathematics > Chemistry > Organic chemistry > General
Books > Science & Mathematics > Biology, life sciences > Biochemistry > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 4-431-54444-5
Barcode: 9784431544449

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners